Catheter Precision, Inc. (VTAK)
- Previous Close
0.6075 - Open
0.5787 - Bid 0.5600 x 1000
- Ask 0.6095 x 4000
- Day's Range
0.5710 - 0.6485 - 52 Week Range
0.3400 - 1.3200 - Volume
87,107 - Avg. Volume
37,563 - Market Cap (intraday)
4.534M - Beta (5Y Monthly) --
- PE Ratio (TTM)
0.05 - EPS (TTM)
11.3000 - Earnings Date Mar 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.10
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
www.catheterprecision.comRecent News: VTAK
Performance Overview: VTAK
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VTAK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VTAK
Valuation Measures
Market Cap
4.60M
Enterprise Value
3.36M
Trailing P/E
0.05
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.23
Price/Book (mrq)
0.25
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-15.36%
Return on Equity (ttm)
-25.18%
Revenue (ttm)
439k
Net Income Avi to Common (ttm)
-6.85M
Diluted EPS (ttm)
11.3000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.49M
Total Debt/Equity (mrq)
1.37%
Levered Free Cash Flow (ttm)
-5.71M
Research Analysis: VTAK
Company Insights: VTAK
VTAK does not have Company Insights